TOG Review (RCOG Journal)

MRCOG Part 2

Maternal Medicine

Adrenal disease and pregnancy

Key Statistics

  • 1 in 3000 — Primary AI prevalence (to 5.5/100,000)
  • 9.5% — Current PPGL fetal mortality
  • 60% — Cushing’s in pregnancy = adrenal adenoma

Don't-miss facts

  1. Adrenal crisis mimics a surgical acute abdomen (pain, vomiting, shock) — treat first, investigate second: IV HC 100 mg 6–8 hourly + 2–3 L 0.9% saline / 5% dextrose saline

  2. Prednisolone ≥5–20 mg/day for ≥3 weeks in pregnancy → IV HC 50–100 mg 8-hourly for up to 24 hours intrapartum. Never stop systemic steroids abruptly (oral or inhaled)

  3. SST cut-off (≥500–550 nmol/L after 250 micrograms Synacthen) is unreliable in pregnancy — if features are suggestive and the SST is indeterminate, treat and retest postpartum

  4. Never give a β-blocker (including labetalol) before α-blockade in PPGL — hypertensive crisis. Crisis agents: IV sodium nitroprusside (first choice), phentolamine, nicardipine

  5. PPGL vs pre-eclampsia: paroxysmal hypertension and orthostatic hypotension do not occur in pre-eclampsia; PPGL has no proteinuria/ankle oedema/raised uric acid and can present at any gestation

  6. Cushing’s in pregnancy: salivary cortisol/UFC >3× upper limit of normal is diagnostic; gadolinium MRI is contraindicated; avoid ketoconazole and mitotane

  7. Dexamethasone should not be used in pregnancy for CAH (not inactivated by 11βHSD2, crosses placenta); continue pre- pregnancy hydrocortisone. Maternal 17-OHP cannot monitor treatment

  8. Primary aldosteronism: eplerenone (FDA class B) over spironolactone (feminisation of male fetus, FGR). No adrenal vein sampling in pregnancy. Resect PPGL before 24 weeks

Key numbers

Primary AI: 1 in 3000–5.5 per 100,000; autoimmune 70–90% HC 15–25 mg/day (2–3 doses) + fludrocortisone 0.05–0.1 mg/day

40 mg HC ≡ 0.1 mg fludrocortisone; on prednisolone ↑fludrocortisone 20–30%

Cortisol peaks at 26 weeks; 2–3× non-pregnant at term; diurnal rhythm preserved

Cushing’s: 60% adrenal adenoma in pregnancy; ACTH <4.4 pmol/L adrenal, >4.4 pituitary

Salivary cortisol: T1 <6.9, T2 <7.2, T3 <9.1 nmol/L PA in pregnancy 0.6–0.8%; renin ↑4× by 8 weeks, 7× in T3

CAH: 21-HD 1:500–1:1000; offspring risk 1:120 classical / 1:250 non-classical

CAH: OGTT at 15 weeks, repeat 24–28 weeks; vaginal delivery in 16–42%

PPGL 1:15,000–1:54,000; fetal mortality 9.5% (7% if diagnosed, 17% if missed)

Abbreviation Key

  • AI — adrenal insufficiency
  • CBG — corticosteroid-binding globulin
  • ACTH — adrenocorticotropic hormone
  • GC — glucocorticoid
  • CRH — corticotropin-/cortisol-releasing hormone
  • MC — mineralocorticoid
  • HC — hydrocortisone
  • 11βHSD2 — 11-β hydroxysteroid dehydrogenase type 2
  • SST — short Synacthen stimulation test
  • 17-OHP — 17-hydroxyprogesterone
  • UFC — urinary free cortisol
  • PPGL — phaeochromocytoma and paraganglioma
  • PA — primary aldosteronism
  • COMT — catechol-O-methyltransferase
  • ARR — aldosterone-to-renin ratio
  • MEN-2 — multiple endocrine neoplasia type 2
  • CAH — congenital adrenal hyperplasia
  • NIPT/NIPD — non-invasive prenatal testing/diagnosis
  • 21-HD — 21-hydroxylase deficiency
  • FGR — fetal growth restriction

Source: Ahmed M, Bashir M, Okunoye GO et al. Adrenal disease and pregnancy: an overview. The Obstetrician & Gynaecologist 2021;23:265–77. doi:10.1111/tog.12761

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free